What are the guidelines for stopping or continuing oral antiplatelet agents (aspirin, clopidogrel, ticagrelor, prasugrel) before an elective surgery in an adult, including exceptions for high thrombotic risk and low‑bleeding‑risk procedures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Perioperative Antiplatelet Management Guidelines

General Principles: Aspirin vs. P2Y12 Inhibitors

Aspirin should be continued throughout the perioperative period for the vast majority of elective surgeries, while P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel) should be discontinued 5-7 days preoperatively unless the patient has high thrombotic risk. 1

The fundamental principle is that thrombotic risk from antiplatelet discontinuation typically exceeds surgical bleeding risk in most patients. 1, 2 This risk-benefit calculation shifts dramatically based on two key factors: the presence of coronary stents and the bleeding risk of the specific procedure.

Timing of Discontinuation for P2Y12 Inhibitors

Standard Elective Surgery (No Recent Stents)

  • Clopidogrel: Stop 5 days before surgery 3, 1, 4
  • Ticagrelor: Stop 5 days before surgery 3
  • Prasugrel: Stop 7 days before surgery 3
  • Aspirin: Continue throughout perioperative period 3, 1

These intervals allow sufficient platelet turnover to restore hemostatic function, as irreversible platelet inhibition lasts 7-10 days (the platelet lifespan). 3, 5

Exception: Aspirin Discontinuation

Aspirin may be stopped 3-7 days preoperatively only in highly selected procedures where even minor bleeding would be catastrophic: 3, 1

  • Intracranial neurosurgery 1
  • Spinal cord surgery 1
  • Posterior chamber eye surgery 1

High Thrombotic Risk: Patients with Coronary Stents

Timing-Based Risk Stratification

Surgery should be postponed whenever possible based on stent timing: 3

  1. Within 1 month of ANY stent placement:

    • Postpone all elective non-cardiac surgery 3
    • If surgery cannot be deferred, perform only in hospitals with 24/7 catheterization laboratory availability 3
    • Consider continuing BOTH aspirin and P2Y12 inhibitor 3

  2. 1-6 weeks after stent (bare-metal or drug-eluting):

    • Continue BOTH antiplatelet agents if possible 3, 1
    • If one agent must be stopped, continue aspirin and stop P2Y12 inhibitor 3
    • Multidisciplinary cardiology consultation mandatory 3

  3. 6 weeks to 3 months after stent:

    • Either continue both agents OR stop P2Y12 inhibitor while continuing aspirin 3
    • Decision depends on: stent type (drug-eluting vs bare-metal), stent location (dominant vessel), number/length of stents, and surgical bleeding risk 3

  4. 3-12 months after stent:

    • Stop P2Y12 inhibitor 5-7 days preoperatively 3
    • Continue aspirin 3

  5. Beyond 12 months after stent:

    • Standard management applies (stop P2Y12 inhibitor, continue aspirin) 3

Additional High-Risk Scenarios Requiring Extended DAPT

Postpone surgery for up to 6 months in: 3

  • Recent myocardial infarction (within 6 months) 3
  • Stents associated with high thrombotic risk (complex lesions, multiple stents, bifurcation stents) 3

Bridging Therapy: Generally NOT Recommended

Routine bridging with IV antiplatelet agents (cangrelor, tirofiban, eptifibatide) or anticoagulants (heparin, LMWH) is NOT recommended. 3

Bridging increases bleeding risk without preventing stent thrombosis, as anticoagulants do not substitute for antiplatelet effects. 1, 5

Exception: Bridging with cangrelor or tirofiban may be considered on a case-by-case basis only when: 3

  • Both antiplatelet agents must be discontinued within 1 month of stent placement 3
  • Performed in ICU setting with 24/7 catheterization laboratory availability 3
  • This is off-label use requiring multidisciplinary discussion 3

Procedure-Specific Bleeding Risk Categories

Low Bleeding Risk (Continue All Antiplatelet Therapy)

Procedures that can be performed on dual antiplatelet therapy: 3

  • Dental extractions
  • Cataract surgery
  • Endoscopy without biopsy
  • Superficial dermatologic procedures

Intermediate Bleeding Risk

Most general surgical procedures fall into this category—follow standard discontinuation guidelines above. 3

High Bleeding Risk

Procedures requiring meticulous hemostasis where P2Y12 inhibitors should be stopped: 3

  • Intracranial surgery
  • Spinal surgery
  • Posterior chamber eye surgery
  • Major cancer resections
  • Cardiac surgery

Regional Anesthesia Considerations

Central Neuraxial Anesthesia (Spinal/Epidural)

  • Aspirin alone: NOT a contraindication to neuraxial blockade 3, 1
  • Any P2Y12 inhibitor: ABSOLUTE CONTRAINDICATION unless discontinued for full duration: 3
    • Clopidogrel: 5 days 3
    • Ticagrelor: 5 days 3
    • Prasugrel: 7 days 3

Single-puncture spinal anesthesia is preferable to epidural when aspirin is continued. 3

Peripheral Nerve Blocks

Low bleeding risk blocks (compressible sites): Can be performed on dual antiplatelet therapy 3

  • Femoral block
  • Axillary brachial plexus block
  • Popliteal sciatic block

High bleeding risk blocks (non-compressible deep sites): 3

  • Can be performed on aspirin monotherapy if benefit/risk favorable 3
  • CONTRAINDICATED on P2Y12 inhibitors unless discontinued per standard timing 3
  • Examples: infraclavicular block, parasacral sciatic block, posterior lumbar plexus block 3

All blocks should use ultrasound guidance by experienced operators. 3

Postoperative Resumption Protocol

Early resumption is critical to minimize thrombotic risk, especially in patients with recent stents. 3, 1

  • Aspirin: Resume within 24 hours after surgery, ideally same day if hemostasis adequate 3, 1
  • P2Y12 inhibitors: Resume within 24-72 hours after surgery 3, 1
  • Use same P2Y12 inhibitor as preoperatively 3
  • Loading dose may be considered in high-risk patients but no definitive recommendation exists 3, 4

Critical Pitfalls to Avoid

  1. Never discontinue BOTH aspirin and P2Y12 inhibitor simultaneously in patients with recent coronary stents (within 12 months)—this dramatically increases stent thrombosis risk with 10% mortality. 1, 5, 2

  2. Do NOT use heparin or LMWH as bridging substitutes for antiplatelet therapy—anticoagulants do not prevent arterial/stent thrombosis and increase bleeding. 1, 5

  3. Do NOT extend clopidogrel discontinuation beyond 5 days—longer intervals increase thrombotic risk without hemostatic benefit. 1

  4. Do NOT administer NSAIDs perioperatively in patients on dual antiplatelet therapy—this compounds bleeding risk. 3

  5. Do NOT perform neuraxial anesthesia on patients taking P2Y12 inhibitors unless fully discontinued per guidelines—risk of epidural hematoma with catastrophic neurologic injury. 3

Special Populations

Coronary Artery Bypass Grafting (CABG)

  • Continue aspirin throughout perioperative period 3
  • Discontinue P2Y12 inhibitors: clopidogrel/ticagrelor 5 days, prasugrel 7 days before surgery 3
  • Multidisciplinary approach to balance bleeding vs thrombotic risk 3

Patients Requiring Oral Anticoagulation

  • Triple therapy (aspirin + P2Y12 inhibitor + anticoagulant) increases bleeding 2-3 fold 3
  • Limit triple therapy to maximum 6 months or omit after hospital discharge 3
  • Do NOT use ticagrelor or prasugrel with anticoagulation—use clopidogrel only 3

References

1
Guideline

Perioperative Management of Antiplatelet and Anticoagulant Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2
Research

Perioperative use of anti-platelet drugs.

Best practice & research. Clinical anaesthesiology, 2007

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

4
Guideline

Perioperative Management of Antiplatelet Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Guideline

Management of Antiplatelet Therapy in Femoral Artery Pseudoaneurysm Before Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Do you hold anticoagulant medication for heart catheterization?
How long should aspirin (acetylsalicylic acid) be held prior to surgery?
Can I give Plavix (clopidogrel) post syndesmosis repair operation?
Should platelet transfusion be given perioperatively or only as a backup in case of bleeding in patients who stopped taking clopidogrel (Plavix) and aspirin 2 days prior to surgery?
How long before surgery should aspirin (acetylsalicylic acid) be stopped?
In an asymptomatic individual with a urine albumin‑creatinine ratio of 10.1 mg/g, what is the appropriate management?
Which bilirubin fractions are removed by therapeutic plasma exchange in a diabetic adult with pancreatic head carcinoma, biliary obstruction, and bile‑cast nephropathy?
How is the ABCDE trauma assessment performed in practice using only the physical examination?
What is the appropriate diagnosis, workup, and management for a patient presenting with pain localized to the hepatic flexure (upper right transverse colon) suggestive of diverticulitis?
Is vaginal hormone replacement therapy safe for a postmenopausal woman with urogenital atrophy symptoms?
In a diabetic adult with pancreatic head carcinoma and biliary obstruction leading to cholestasis, does the delta‑bilirubin fraction cause kidney injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question